TXG Form 144: Morgan Stanley Plans Common Sale

TXG filed a Form 144 reporting a proposed sale of common stock by Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

TXG filed a Form 144 reporting a proposed sale of common stock by Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists restricted stock lots of 3,740 shares dated 11/21/2025 and 3,839 shares dated 08/21/2025.

Insights

Securities Compliance Counsel

Routine Form 144 notice showing proposed broker-held restricted stock sales.

The filing lists proposed dispositions of common stock held as restricted stock with lot dates 11/21/2025 (3,740 shares) and 08/21/2025 (3,839 shares). This is a notice of intent to sell under resale rules.

Form 144s are procedural disclosures; execution method, timing, and proceeds are governed by applicable resale and broker procedures and are not detailed in the excerpt.

FAQ

What does TXG's Form 144 disclose?

The Form 144 discloses a proposed sale of TXG common stock by a broker. It lists restricted stock lots of 3,740 shares dated 11/21/2025 and 3,839 shares dated 08/21/2025 as the securities to be sold.

Who is the selling party on the TXG Form 144?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the selling intermediary. The entry appears under the broker/seller line associated with the proposed sale of TXG common stock.

Do the TXG filing dates indicate when the shares will be sold?

The dates shown (11/21/2025 and 08/21/2025) are grant or restricted stock dates for the listed lots. The Form 144 excerpt does not provide execution timing or settlement dates for any sale transactions.

How many TXG shares are listed for potential sale in the excerpt?

The excerpt lists two restricted stock lots totaling visible counts of 3,740 shares and 3,839 shares tied to their respective grant dates. The document does not aggregate or show additional holder rows in the provided text.

Does the Form 144 disclose proceeds or pricing for the TXG sale?

The provided excerpt does not include dollar proceeds or pricing information. The filing entries list share counts and dates for restricted stock but do not state sale price or aggregate proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002030916
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	10X GENOMICS, INC.
SEC File Number	001-39035
Address of Issuer	6230 Stoneridge Mall Road Pleasanton CALIFORNIA 94588
Phone	(925) 401-7300
Name of Person for Whose Account the Securities are To Be Sold	SARAH A POLONIUS-TEICHMANN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7579	147108.39	117673382	02/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/21/2025	Restricted Stock	ISSUER			3740	11/21/2025	Not Applicable
Common	08/21/2025	Restricted Stock	ISSUER			3839	08/21/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sarah Amalia Polonius-Teichmann
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)